Recent News

To help you stay informed of exciting activities and milestones at Surmodics, we have listed some of the key items below.

Document Title Release Date Category
Surmodics Expands Protein-Free Stabilizer Line with AP Option 07/28/2014 In Vitro Diagnostics
Therapeutic Coatings for Medical Device Implants 03/20/2014 Medical Device
Surmodics IVD Breakthrough Stabilizer Addresses Industry Challenge 07/26/2013 In Vitro Diagnostics
The Evolution of Coatings for Endovascular Devices 05/03/2013 Medical Device
Surmodics’ New Low Friction, Low Particulate Device Coatings Introduced 02/11/2013 Medical Device
Surmodics Appoints Andy LaFrence as Chief Financial Officer 12/28/2012 Corporate
Return to growth for Surmodics 09/20/2012 Corporate
Surmodics IVD to Launch New Product at AACC in Los Angeles, CA 07/09/2012 In Vitro Diagnostics
New Website Reflects Strategic Focus 05/22/2012 Corporate
Surmodics IVD to Present at Biomarker World Congress in Philadelphia, PA 05/21/2012 In Vitro Diagnostics
Surmodics IVD Introduces New StabilBlot Blocker Family 04/17/2012 In Vitro Diagnostics
Minnesota supplier to benefit from FDA OK of Medtronic heart stent 03/05/2012 Medical Device
Surmodics’ Hydrophilic Coating on Medtronic’s Resolute Integrity™ Drug-Eluting Stent Delivery System 03/03/2012 Medical Device
Drug-Delivery Technologies Show Some Backbone 11/18/2011 Medical Device
Surmodics IVD Introduces a New BioFX® TMB Enhanced HRP Membrane Substrate 09/20/2011 In Vitro Diagnostics
Surmodics Introduces New In Vitro Diagnostics Product:  Surmodics® Assay Diluent (Protein-Free) 07/26/2011 In Vitro Diagnostics